Cargando…

Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure

BACKGROUND: Early recognition of anthracycline-induced cardiomyopathy may reduce morbidity and mortality in children, but risk stratification tools are lacking. This study evaluates whether electrocardiogram (ECG) changes precede echocardiographic abnormalities in children with anthracycline-induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desai, Lajja, Balmert, Lauren, Reichek, Jennifer, Hauck, Amanda, Gambetta, Katheryn, Webster, Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048097/ https://www.ncbi.nlm.nih.gov/pubmed/32154016 http://dx.doi.org/10.1186/s40959-019-0045-6

Ejemplares similares

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

Electrocardiogram in arrhytmogenic cardiomyopathy
por: Calò, Leonardo, et al.
Publicado: (2023)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
por: Thompson, Kara Annette
Publicado: (2018)

Risk stratification in cardiomyopathy
por: Sinagra, Gianfranco, et al.
Publicado: (2020)

Left ventricular hypertrophy in hypertension: Is the electrocardiogram enough for risk stratification?
por: Cuspidi, Cesare, et al.
Publicado: (2022)

Outcomes in patients with anthracycline‐induced cardiomyopathy undergoing left ventricular assist devices implantation
por: Guha, Avirup, et al.
Publicado: (2021)

The electrocardiogram in non-ischaemic-dilated cardiomyopathy
por: Crescenzi, Cinzia, et al.
Publicado: (2023)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Genetic Testing in Evaluating Risk of Anthracycline Cardiomyopathy: Are We There Yet?
por: Wong-Siegel, Jeannette R., et al.
Publicado: (2023)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011)

Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
por: Nettersheim, Felix Sebastian, et al.
Publicado: (2023)

Near missed reversible cardiomyopathy: The value of the electrocardiogram
por: Al-Fayyadh, Majid, et al.
Publicado: (2015)

The Usefulness of Surface Electrocardiogram as a Prognostic Predictor in Children with Idiopathic Dilated Cardiomyopathy
por: Huh, June, et al.
Publicado: (2004)

Risk stratification in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2018)

Anthracycline-induced cardiomyopathy: Is there a new light at the end of the tunnel?
por: Fradley, Michael G., et al.
Publicado: (2021)

Clinical characteristics and risk stratification of desmoplakin cardiomyopathy
por: Wang, Weijia, et al.
Publicado: (2021)

Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
por: Du, Darson, et al.
Publicado: (2022)

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Wallace, Ryan, et al.
Publicado: (2021)

Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
por: Distefano, Giuseppe
Publicado: (2009)

Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines
por: Tagawa, Michihito, et al.
Publicado: (2021)

Shark Fin Electrocardiogram: A Deadly Electrocardiogram Pattern in Takotsubo Cardiomyopathy During 15 Years of Follow-Up
por: Almutairi, Atheer M, et al.
Publicado: (2023)

The Changes of T-Wave Amplitude and QT Interval Between the Supine and Orthostatic Electrocardiogram in Children With Dilated Cardiomyopathy
por: Tan, Cheng, et al.
Publicado: (2021)

Simple screening model based on electrocardiogram for patients with dilated cardiomyopathy
por: Wang, Xiangyu, et al.
Publicado: (2023)

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy
por: Santoro, Francesco, et al.
Publicado: (2023)

Value of cardiac magnetic resonance on the risk stratification of cardiomyopathies
por: Vidal-Perez, Rafael, et al.
Publicado: (2023)

Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
por: Gasperetti, Alessio, et al.
Publicado: (2023)

A case series about the favorable effects of sacubitril/valsartan on anthracycline cardiomyopathy
por: De Vecchis, Renato, et al.
Publicado: (2020)

Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
por: McOwan, Timothy N., et al.
Publicado: (2020)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Electrocardiogram in apical hypertrophic cardiomyopathy with a speculation as to the mechanism of its features
por: Madias, J. E.
Publicado: (2013)

An Upgrade on the Rabbit Model of Anthracycline-Induced Cardiomyopathy: Shorter Protocol, Reduced Mortality, and Higher Incidence of Overt Dilated Cardiomyopathy
por: Talavera, Jesús, et al.
Publicado: (2015)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
por: Mabudian, Leila, et al.
Publicado: (2022)

Native myocardial T1 time can predict development of subsequent anthracycline‐induced cardiomyopathy
por: Muehlberg, Fabian, et al.
Publicado: (2018)

Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Bhatia, Smita
Publicado: (2020)

The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy
por: Shiga, Tsuyoshi, et al.
Publicado: (2021)

Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
por: Leerink, Jan M., et al.
Publicado: (2021)

Early myocardial oedema can predict subsequent cardiomyopathy in high‐dose anthracycline therapy
por: Muehlberg, Fabian, et al.
Publicado: (2022)

Interpretation of electrocardiograms in infants and children
por: Tipple, M
Publicado: (1999)

Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
por: Jordà, Paloma, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h0sjo00bttiafto0dhod9jvo62